Michael M. Wick
Overview
Michael M. Wick received an average of $871K in total compensation, including $464K in salary, at MabVax Therapeutics Holdings from 2006 to 2014.
2014MabVax Therapeutics HoldingsFormer President, Chief Executive Officer and Chairman
2013MabVax Therapeutics HoldingsFormer President, Chief Executive Officer and Chairman
2012MabVax Therapeutics HoldingsPresident, Chief Executive Officer and Chairman
2011MabVax Therapeutics HoldingsPresident, Chief Executive Officer and Chairman
2010MabVax Therapeutics HoldingsPresident, Chief Executive Officer and Chairman
2009MabVax Therapeutics HoldingsPresident, Chief Executive Officer and Chairman
2008MabVax Therapeutics HoldingsPresident, Chief Executive Officer and Chairman
2007MabVax Therapeutics HoldingsPresident, Chief Executive Officer and Chairman
2006MabVax Therapeutics HoldingsPresident, Chief Executive Officer and Chairman
Source: SEC filings on May 27, 2016, July 27, 2015, April 5, 2013, March 5, 2012, April 7, 2010, and April 10, 2009.
Related executives
We found 11 more executives who work or worked at MabVax Therapeutics Holdings.
J Hansen
MabVax Therapeutics Holdings
Chief Executive Officer
Paul Resnick
MabVax Therapeutics Holdings
Vice President, Chief Business Officer
Paul Maffuid
MabVax Therapeutics Holdings
Vice President, Pharmaceutical Development and Operations
Gregory Hanson
MabVax Therapeutics Holdings
Chief Financial Officer
Wolfgang Scholz
MabVax Therapeutics Holdings
Vice President, Antibody Discovery
William Kaplan
MabVax Therapeutics Holdings
General Counsel
Wendy Wee
MabVax Therapeutics Holdings
Vice President, Finance and Controller
Steven Schow
MabVax Therapeutics Holdings